{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:06:04Z","timestamp":1791493564810,"version":"4.3.4"},"reference-count":294,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jconrel.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:00:45Z","timestamp":1715979645000},"page":"773-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Spleen-targeted delivery systems and strategies for spleen-related diseases"],"prefix":"10.1016","volume":"370","author":[{"given":"Ziyao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhile","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.jconrel.2024.05.007_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/17425247.2.3.419","article-title":"Strategies to improve oral drug bioavailability","volume":"2","author":"Gomez-Orellana","year":"2005","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody-drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0020","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000443526","article-title":"Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine","volume":"8","author":"Valent","year":"2016","journal-title":"J. Innate. Immun."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb0030","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1803","article-title":"Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria","volume":"14","author":"Shi","year":"2022","journal-title":"Wiley Interdiscip. Rev Nanomed. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","article-title":"Strategies for non-viral vectors targeting organs beyond the liver","volume":"19","author":"Kim","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101943","article-title":"Spleen-targeted nanosystems for immunomodulation","volume":"52","author":"Wang","year":"2023","journal-title":"Nano Today"},{"issue":"23","key":"10.1016\/j.jconrel.2024.05.007_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.28940","article-title":"Personalised cancer medicine","volume":"137","author":"Jackson","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/imm.12469","article-title":"Human spleen microanatomy: why mice do not suffice","volume":"145","author":"Steiniger","year":"2015","journal-title":"Immunology"},{"issue":"5847","key":"10.1016\/j.jconrel.2024.05.007_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.1146291","article-title":"In situ imaging of the endogenous CD8 T cell response to infection","volume":"318","author":"Khanna","year":"2007","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.jconrel.2024.05.007_bb0085","doi-asserted-by":"crossref","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0090","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/emboj.2012.87","article-title":"The location of splenic NKT cells favours their rapid activation by blood-borne antigen","volume":"31","author":"Barral","year":"2012","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/icb.2008.22","article-title":"Geography and plumbing control the T cell response to infection","volume":"86","author":"Khanna","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb0105","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/IAI.00115-17","article-title":"Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen","volume":"85","author":"Machelart","year":"2017","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4049\/jimmunol.0900870","article-title":"Marginal Zone Precursor B Cells as Cellular Agents for Type I IFN\u2013Promoted Antigen Transport in Autoimmunity","volume":"184","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9561350","article-title":"Neutrophil-Derived MRP14 Supports Plasma Cell Commitment and Protects Myeloma Cells from Apoptosis","volume":"2019","author":"Zhao","year":"2019","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/01926230600867743","article-title":"Normal structure, function, and histology of the spleen","volume":"34","author":"Cesta","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(08)62453-5","article-title":"Cells in the marginal zone of the spleen","volume":"132","author":"Kraal","year":"1992","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0130","doi-asserted-by":"crossref","unstructured":"B. Steiniger, P. Barth, Microanatomy and function of the spleen, Regulat. Implantat. Establish. Pregnan. Mamm. 151 (2000) III-IX, 1-101.","DOI":"10.1007\/978-3-642-57088-9_1"},{"issue":"23","key":"10.1016\/j.jconrel.2024.05.007_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent advances of emerging spleen-targeting nanovaccines for immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151975","article-title":"Resting innate-like B cells leverage sustained Notch2\/mTORC1 signaling to achieve rapid and mitosis-independent plasma cell differentiation","author":"Gaudette","year":"2021","journal-title":"J. Clin. Invest. 131(20)"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20021801","article-title":"A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp","volume":"198","author":"Nolte","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6581","key":"10.1016\/j.jconrel.2024.05.007_bb0150","doi-asserted-by":"crossref","first-page":"eabi5965","DOI":"10.1126\/science.abi5965","article-title":"CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells","volume":"375","author":"Liu","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular Helper T Cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb0160","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.177.7.4927","article-title":"ICOS deficiency is associated with a severe reduction of CXCR5 CD4 germinal center Th cells","volume":"177","author":"Bossaller","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","article-title":"Circulating Precursor CCR7 PD-1 CXCR5 CD4 T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure","volume":"39","author":"He","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0170","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.jconrel.2024.05.007_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"35","key":"10.1016\/j.jconrel.2024.05.007_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6326","article-title":"A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine","volume":"7","author":"Zhai","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1738813","article-title":"Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses","volume":"9","author":"D\u00f6len","year":"2020","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb0190","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1021\/acs.nanolett.1c01133","article-title":"Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines","volume":"21","author":"Jiang","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0195","doi-asserted-by":"crossref","first-page":"101943","DOI":"10.1016\/j.nantod.2023.101943","article-title":"Spleen-targeted nanosystems for immunomodulation","volume":"52","author":"Fazhan","year":"2023","journal-title":"Nano Today"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imr.12979","article-title":"Macrophage-fibroblast circuits in the spleen","volume":"302","author":"Bellomo","year":"2021","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0210","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pt.2020.03.001","article-title":"The Human Spleen in Malaria: Filter or Shelter?","volume":"36","author":"Henry","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0215","doi-asserted-by":"crossref","first-page":"617879","DOI":"10.3389\/fcell.2020.617879","article-title":"Tissue-Resident Macrophage Development and Function","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Cell Developm. Biol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.me.37.020186.000405","article-title":"The role of the spleen in resistance to infection","volume":"37","author":"Bohnsack","year":"1986","journal-title":"Annu. Rev. Med."},{"issue":"67","key":"10.1016\/j.jconrel.2024.05.007_bb0225","doi-asserted-by":"crossref","first-page":"eabj0641","DOI":"10.1126\/sciimmunol.abj0641","article-title":"A diverse fibroblastic stromal cell landscape in the spleen directs tissue homeostasis and immunity","volume":"7","author":"Alexandre","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2022.04.005","article-title":"Re-directing nanomedicines to the spleen: A potential technology for peripheral immunomodulation","volume":"350","author":"Kaur","year":"2022","journal-title":"J. Control. Release"},{"issue":"44","key":"10.1016\/j.jconrel.2024.05.007_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300095120","article-title":"Physical mechanisms of red blood cell splenic filtration","volume":"120","author":"Moreau","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0240","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0245","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/bc200111p","article-title":"Biologically Optimized Nanosized Molecules and Particles: More than Just Size","volume":"22","author":"Longmire","year":"2011","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41401-018-0052-4","article-title":"Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"16","key":"10.1016\/j.jconrel.2024.05.007_bb0265","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"P Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jemt.20408","article-title":"Contribution of high-resolution correlative imaging techniques in the study of the liver sieve in three-dimensions","volume":"70","author":"Braet","year":"2007","journal-title":"Microsc. Res. Tech."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug-carrier in the body: An anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2011","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0280","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V41.4.529.529","article-title":"The Role of the Sinus Wall in the Passage of Erythrocytes Through the Spleen","volume":"41","author":"Chen","year":"1973","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0285","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0006-291X(91)91869-E","article-title":"Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating","volume":"177","author":"Moghimi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0290","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","article-title":"Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective","volume":"52","author":"Moghimi","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"21","key":"10.1016\/j.jconrel.2024.05.007_bb0295","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","article-title":"Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery","volume":"17","author":"Xu","year":"2023","journal-title":"Target., Clearan., Acs Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0300","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0305","doi-asserted-by":"crossref","first-page":"16625","DOI":"10.1021\/acsnano.1c06460","article-title":"Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant Staphylococcus aureus Pneumonia Treatment and Prevention","volume":"15","author":"Lin","year":"2021","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb0310","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/ard.2009.108985","article-title":"Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis","volume":"68","author":"Rauchhaus","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.jconrel.2024.05.007_bb0320","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1039\/C5CS00217F","article-title":"The nanoparticle biomolecule corona: lessons learned - challenge accepted?","volume":"44","author":"Docter","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0325","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2022.03.048","article-title":"Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy","volume":"345","author":"Du","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0330","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Longze","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0335","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0340","doi-asserted-by":"crossref","first-page":"e2202528","DOI":"10.1002\/adhm.202202528","article-title":"Delivering mRNA to secondary lymphoid tissues by phosphatidylserine-loaded lipid nanoparticles","volume":"12","author":"Gomi","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0345","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s12274-020-3175-0","article-title":"Efficient delivery of clay-based nanovaccines to the mouse spleen promotes potent anti-tumor immunity for both prevention and treatment of lymphoma","volume":"14","author":"Zhang","year":"2021","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100923","article-title":"Nanovaccine's rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"issue":"7607","key":"10.1016\/j.jconrel.2024.05.007_bb0355","doi-asserted-by":"crossref","first-page":"396-+","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0360","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s12274-023-6111-2","article-title":"Natural long-chain saturated fatty acids doped LNPs enabling spleen selective mRNA translation and potent cancer immunotherapy","volume":"17","author":"Wang","year":"2023","journal-title":"Nano Res"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb0365","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/ard.2009.108985","article-title":"Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis","volume":"68","author":"Rauchhaus","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0370","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1021\/acsnano.2c08898","article-title":"Development of Spleen Targeting H2S Donor Loaded Liposome for the Effective Systemic Immunomodulation and Treatment of Inflammatory Bowel Disease","volume":"17","author":"Oh","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0375","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2015.08.037","article-title":"Development of 4-sulfated -acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis","volume":"136","author":"Tripathi","year":"2015","journal-title":"Col. Surf. B"},{"issue":"1-2","key":"10.1016\/j.jconrel.2024.05.007_bb0380","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2007.10.014","article-title":"Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis","volume":"352","author":"Ye","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb0385","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1021\/acsnano.6b06451","article-title":"Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis","volume":"10","author":"Yi","year":"2016","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202528","article-title":"Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles","volume":"12","author":"Gomi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0395","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jconrel.2021.01.005","article-title":"Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen","volume":"330","author":"Kimura","year":"2021","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.jconrel.2024.05.007_bb0400","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1039\/C5NR00520E","article-title":"Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide","volume":"7","author":"Hajipour","year":"2015","journal-title":"Nanoscale"},{"issue":"48","key":"10.1016\/j.jconrel.2024.05.007_bb0405","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1039\/C7TB01689A","article-title":"Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries","volume":"5","author":"Amani","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2023.06.014","article-title":"The role of protein corona on nanodrugs for organ-targeting and its prospects of application","volume":"360","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"issue":"16","key":"10.1016\/j.jconrel.2024.05.007_bb0415","article-title":"The Impact of Protein Corona Formation on the Macrophage Cellular Uptake and Biodistribution of Spherical","volume":"13","author":"Chinen","year":"2017","journal-title":"Nucleic Acids, Small"},{"issue":"48","key":"10.1016\/j.jconrel.2024.05.007_bb0420","doi-asserted-by":"crossref","first-page":"32723","DOI":"10.1021\/acsami.6b12481","article-title":"Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo","volume":"8","author":"Nissinen","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0425","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2022.03.048","article-title":"Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy","volume":"345","author":"Du","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127802","article-title":"Recent advances in fluorescence nanoparticles \"quantum dots\" as gene delivery system: A review","volume":"254","author":"Zahed","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"15","key":"10.1016\/j.jconrel.2024.05.007_bb0435","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1021\/am509096x","article-title":"Comparative Study of Potential Applications of Graphene, MoS, and other two-dimensional materials in energy devices, sensors, and related areas","volume":"7","author":"Rao","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0440","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0168-3659(01)00402-3","article-title":"Microscopic localization of PEG-liposomes in a rat model of focal infection","volume":"75","author":"Laverman","year":"2001","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0450","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1021\/acsnano.2c08898","article-title":"Development of Spleen Targeting H2S Donor Loaded Liposome for the Effective Systemic Immunomodulation and Treatment of Inflammatory Bowel Disease","volume":"17","author":"Oh","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0455","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00418-022-02086-0","article-title":"A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice","volume":"157","author":"Abu-Dief","year":"2022","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2003.11.018","article-title":"enzyme and peptide delivery using erythrocytes as carriers","volume":"95","author":"Mill\u00e1n","year":"2004","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0465","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2019-129351","article-title":"Improvement in Red Blood Cell Physiology in Children with Sickle Cell Anemia Receiving Voxelotor","volume":"134","author":"Chonat","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0470","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/713840329","article-title":"Carrier erythrocytes: an overview","volume":"10","author":"Hamidi","year":"2003","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0475","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4049\/jimmunol.176.1.441","article-title":"Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation","volume":"176","author":"Ing","year":"2005","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.jconrel.2024.05.007_bb0480","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2010.02.013","article-title":"In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy","volume":"28","author":"Banz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0485","doi-asserted-by":"crossref","first-page":"101280","DOI":"10.1016\/j.nantod.2021.101280","article-title":"Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes","volume":"40","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0490","series-title":"Proceedings of the National Academy of Sciences of the United States of America","article-title":"Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function","author":"Ukidve","year":"2020"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0495","series-title":"Proceedings of the National Academy of Sciences of the United States of America","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease [Immunology and Inflammation]","author":"Pishesha","year":"2017"},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0500","doi-asserted-by":"crossref","first-page":"eaaw6870","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","volume":"5","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"issue":"35","key":"10.1016\/j.jconrel.2024.05.007_bb0505","doi-asserted-by":"crossref","first-page":"eabi6326","DOI":"10.1126\/sciadv.abi6326","article-title":"A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine","volume":"7","author":"Zhai","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0510","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0515","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","article-title":"Neutrophil hitchhiking for drug delivery to the bone marrow","volume":"18","author":"Luo","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0520","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s42255-023-00853-4","article-title":"Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer","volume":"5","author":"Wang","year":"2023","journal-title":"Nat. Metabol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0525","first-page":"608","article-title":"CCL9\/CCR1 induces myeloid\u2011derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model","volume":"41","author":"Li","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0530","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2015.08.053","article-title":"The modulation of biodistribution of stem cells by anchoring lipid-conjugated heparin on the cell surface","volume":"217","author":"Kim","year":"2015","journal-title":"J. Control. Release"},{"issue":"24","key":"10.1016\/j.jconrel.2024.05.007_bb0535","doi-asserted-by":"crossref","first-page":"37081","DOI":"10.18632\/oncotarget.9464","article-title":"Exploiting macrophages as targeted carrier to guide nanoparticles into glioma","volume":"7","author":"Pang","year":"2016","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.jconrel.2024.05.007_bb0540","doi-asserted-by":"crossref","first-page":"1910304","DOI":"10.1002\/adfm.201910304","article-title":"Real-Time Imaging Tracking of Engineered Macrophages as Ultrasound-Triggered Cell Bombs for Cancer Treatment","volume":"30","author":"Xu","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb0545","doi-asserted-by":"crossref","first-page":"1604916","DOI":"10.1002\/adfm.201604916","article-title":"A Versatile Plasma Membrane Engineered Cell Vehicle for Contact-Cell-Enhanced Photodynamic Therapy","volume":"27","author":"Li","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2017.04.012","article-title":"Cell-borne 2D nanomaterials for efficient cancer targeting and photothermal therapy","volume":"133","author":"Li","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0555","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1038\/s41598-020-68874-7","article-title":"Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes","volume":"10","author":"Haney","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0560","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","article-title":"Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy","volume":"17","author":"He","year":"2017","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb0565","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.jconrel.2024.05.007_bb0570","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1021\/acsami.3c00494","article-title":"Spleen-Targeted mRNA Delivery by Amphiphilic Carbon Dots for Tumor Immunotherapy","volume":"15","author":"Chen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0575","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216836","article-title":"Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma","volume":"15","author":"Wu","year":"2023","journal-title":"Embo. Mol. Med."},{"issue":"39","key":"10.1016\/j.jconrel.2024.05.007_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204976","article-title":"Spleen-Targeted Glabridin-Loaded Nanoparticles Regulate Polarization of Monocyte\/Macrophage (M(o) \/M(phi)) for the Treatment of Cerebral Ischemia-Reperfusion Injury","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0585","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2021-148322","article-title":"Splenomegaly Study (SMS): Which Etiologies for Unexplained Splenomegalies?","volume":"138","author":"Denis","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0590","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1102\/1470-7330.2010.0026","article-title":"Review: Primary and secondary neoplasms of the spleen","volume":"10","author":"Kaza","year":"2010","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0595","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijsu.2015.01.018","article-title":"Hemangiopericytoma of the spleen","volume":"15","author":"Illuminati","year":"2015","journal-title":"Int. J. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0600","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/RLU.0b013e318281652c","article-title":"FDG uptake in splenic epidermoid cyst with hemorrhage","volume":"39","author":"Dong","year":"2014","journal-title":"Clin. Nucl. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0605","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2021012386","article-title":"Genetic and phenotypic attributes of splenic marginal zone lymphoma","volume":"139","author":"Bonfiglio","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0610","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12943-022-01687-6","article-title":"Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling","volume":"21","author":"Rizzello","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.5555","article-title":"Hepatosplenic \u03b3\u03b4 T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome)","volume":"69","author":"Motta","year":"2002","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0620","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0625","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.148.1.6856834","article-title":"Large-cell lymphoma of the spleen: CT appearance","volume":"148","author":"Meyer","year":"1983","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0630","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLU.0000000000000403","article-title":"Differentiation of an unclear splenic lesion in a patient with cholangiocarcinoma","volume":"39","author":"Lapa","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0635","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2016.08.002","article-title":"NF-\u03baB deregulation in splenic marginal zone lymphoma","volume":"39","author":"Spina","year":"2016","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0640","first-page":"348","article-title":"Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma","volume":"37","author":"Yan","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0645","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal. Transd. Target Ther"},{"issue":"24","key":"10.1016\/j.jconrel.2024.05.007_bb0650","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1182\/blood-2010-12-325944","article-title":"CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling","volume":"118","author":"Hampel","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0655","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.jconrel.2024.05.007_bb0660","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0665","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0670","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ajh.27058","article-title":"Marginal zone lymphoma: 2023 update on diagnosis and management","volume":"98","author":"Cheah","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0675","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood-2018-02-833608","article-title":"Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance","volume":"132","author":"Kalpadakis","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0680","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/bjh.15641","article-title":"Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA\/IELSG36 study","volume":"183","author":"Iannitto","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12032-017-1076-1","article-title":"First-line treatment with bendamustine and rituximab, in patients with intermediate-\/high-risk splenic marginal zone lymphomas","volume":"35","author":"Castelli","year":"2017","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0690","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.clml.2022.03.004","article-title":"Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma","volume":"22","author":"Alhaj Moustafa","year":"2022","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0695","article-title":"Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review","volume":"19","author":"Guan","year":"2023","journal-title":"Recent Patent. Anti-Cancer Drug Discov."},{"issue":"25","key":"10.1016\/j.jconrel.2024.05.007_bb0700","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/sj.onc.1210378","article-title":"Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab","volume":"26","author":"Davies","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0705","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14504","article-title":"Tandem high-dose chemotherapy followed by autologous stem cell transplantation: An infant with trilateral retinoblastoma","volume":"27","author":"Toret","year":"2023","journal-title":"Pediatr. Transplant."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0710","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0715","series-title":"High-Dose Chemotherapy and autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma:a Multi-Centre Retrospective Analysis from the United Kingdom","author":"Kassam","year":"2017"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.05.002","article-title":"Decreased mortality in 1-Year survivors of umbilical cord blood transplant vs. matched related or matched unrelated donor transplant in patients with hematologic malignancies","volume":"27","author":"Bohannon","year":"2021","journal-title":"Transpl. Cell Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0725","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.seminhematol.2016.01.007","article-title":"Cord blood versus haploidentical stem cell transplantation for hematological malignancies","volume":"53","author":"Kekre","year":"2016","journal-title":"Semin. Hematol."},{"issue":"22","key":"10.1016\/j.jconrel.2024.05.007_bb0730","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.2008.2008","article-title":"Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion- Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study","volume":"128","author":"Rose","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0735","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3324\/haematol.2014.105908","article-title":"Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation","volume":"99","author":"Vallejo","year":"2014","journal-title":"Haematologica (Roma)"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0740","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bmt.2016.326","article-title":"Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML","volume":"52","author":"Legrand","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0745","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41409-020-0798-4","volume":"55","author":"Kothari","year":"2020","journal-title":"Bone Marrow Transplantat. (Basingstoke)"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0750","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bmt.1705278","article-title":"Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies","volume":"37","author":"Petropoulos","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0755","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3324\/haematol.2020.265769","article-title":"Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study","volume":"107","author":"Greinix","year":"2022","journal-title":"Haematologica (Roma)"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0760","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1705271","article-title":"Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect","volume":"37","author":"Dasgupta","year":"2006","journal-title":"Bone Marrow Transplantat. (Basingstoke)"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0765","first-page":"2312","year":"2019","journal-title":"Hematol. Week"},{"key":"10.1016\/j.jconrel.2024.05.007_bb0770","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-113461","article-title":"Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine\/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis","volume":"132","author":"Mino","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0775","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbmt.2014.09.024","article-title":"Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population","volume":"21","author":"Brammer","year":"2015","journal-title":"Biol. Blood Marrow Tr"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0780","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4103\/0973-1482.151418","article-title":"Lenalidomide in relapsed refractory non-Hodgkin\u2019s lymphoma: An Indian perspective","volume":"11","author":"Lakshmaiah","year":"2015","journal-title":"J. Cancer Res. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0785","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2009.11.001","article-title":"Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin\u2019s lymphoma","volume":"64","author":"Machover","year":"2010","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0790","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0795","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0800","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2012.46.8793","article-title":"Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas","volume":"32","author":"Friedberg","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0805","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncr.34544","article-title":"Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China","volume":"129","author":"Gao","year":"2023","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0810","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/eji.201848042","article-title":"Rituximab\/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies","volume":"49","author":"Ames","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2024.05.007_bb0815","article-title":"Phase I\/II study of intratumoral injection of SD-101, an immunostimulatory CpG, and intratumoral injection of ipillumumab, an anti-CTLA-4 monoclonal antibody, in combination with local radiation in low-grade B-cell lymphomas","volume":"33","author":"Khodadoust","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.jconrel.2024.05.007_bb0820","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-19-0438","article-title":"A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed\/Refractory B-Cell Lymphoma","volume":"25","author":"Tuscano","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"46","key":"10.1016\/j.jconrel.2024.05.007_bb0825","doi-asserted-by":"crossref","first-page":"E7240","DOI":"10.1073\/pnas.1608555113","article-title":"Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8 <sup>+<\/sup> T cells","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.967026","article-title":"The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0835","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbmt.2013.11.029","article-title":"A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B\u00a0Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients","volume":"20","author":"Sauter","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb0840","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaoncol.2022.1968","article-title":"Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase\u2013Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer\/T-Cell Lymphoma","volume":"8","author":"Wang","year":"2022","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0845","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ejh.13568","article-title":"Combination of brentuximab\u2010vedotin and ifosfamide, carboplatin, etoposide in relapsed\/refractory peripheral T\u2010cell lymphoma","volume":"106","author":"Van De Wyngaert","year":"2021","journal-title":"Eur. J. Haematol."},{"issue":"19","key":"10.1016\/j.jconrel.2024.05.007_bb0850","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.21.02678","article-title":"Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma","volume":"40","author":"Teachey","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb0855","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/annonc\/mdh384","article-title":"Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity","volume":"15","author":"Rozados","year":"2004","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0860","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/2040620715625966","article-title":"The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia","volume":"7","author":"Nair","year":"2016","journal-title":"Ther. Adv. Hematol."},{"issue":"28","key":"10.1016\/j.jconrel.2024.05.007_bb0865","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.21.01056","article-title":"Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma","volume":"39","author":"Moskowitz","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb0870","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and Treatment of Chronic Lymphocytic Leukemia","volume":"329","author":"Shadman","year":"2023","journal-title":"J. Am. Med. Assoc."},{"issue":"14","key":"10.1016\/j.jconrel.2024.05.007_bb0875","first-page":"1819","article-title":"Temsirolimus, Drugs : international journal of current therapeutics and applied pharmacology reviews, featuring evaluations on newdrugs, review articles on drugs and drug therapy, and drug literature abstracts","volume":"70","author":"Hoy","year":"2010"},{"issue":"15","key":"10.1016\/j.jconrel.2024.05.007_bb0880","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.jconrel.2024.05.007_bb0885","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.V118.21.3718.3718","article-title":"Safety and Efficacy of the Novel Combination of Panobinostat (LBH589) and Everolimus (RAD001) in Relapsed\/Refractory Hodgkin and Non-Hodgkin Lymphoma","volume":"118","author":"Younes","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0890","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/13543784.2013.815165","article-title":"Panobinostat in lymphoid and myeloid malignancies","volume":"22","author":"Khot","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0895","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.2008.07353.x","article-title":"Phase II multicenter study of oblimersen sodium, a Bcl\u20102 antisense oligonucleotide, in combination with rituximab in patients with recurrent B\u2010cell non\u2010Hodgkin lymphoma","volume":"143","author":"Pro","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0900","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63434-5","article-title":"Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma","volume":"10","author":"Alonso-Alonso","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0905","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx697.030","article-title":"Treatment with R-bendamustine followed by Y-90 ibritumomab tiuxetan for relapsed\/refractory low-grade B-cell lymphoma","volume":"28","author":"Nikkuni","year":"2017","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb0910","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/cas.14933","article-title":"Chemotherapy for non\u2010Hodgkin lymphoma in the hemodialysis patient: A comprehensive review","volume":"112","author":"Yasuda","year":"2021","journal-title":"Cancer Sci."},{"issue":"20","key":"10.1016\/j.jconrel.2024.05.007_bb0915","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1158\/1078-0432.CCR-09-1339","article-title":"Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma","volume":"15","author":"Ansell","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.jconrel.2024.05.007_bb0920","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1158\/1078-0432.CCR-09-1339","article-title":"Phase I Study of Ipilimumab, an Anti\u2013CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non\u2013Hodgkin Lymphoma","volume":"15","author":"Ansell","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0925","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40164-019-0126-0","article-title":"Mantle cell lymphoma and its management: Where are we now?","volume":"8","author":"Ladha","year":"2019","journal-title":"Experiment. Hematol. & Oncol."},{"issue":"21","key":"10.1016\/j.jconrel.2024.05.007_bb0930","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.4126.4126","article-title":"Bendamustine (Treanda\u00ae), Etoposide and Dexamethasone (BED) Followed by GCSF Effectively Mobilizes Autologous Peripheral Blood Hematopoietic Stem Cells","volume":"120","author":"Green","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0935","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/bmt.2011.170","article-title":"Novel agents and approaches for stem cell mobilization in normal donors and patients","volume":"47","author":"Bakanay","year":"2012","journal-title":"Bone Marrow Transplantat. (Basingstoke)"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb0940","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajh.24693","article-title":"A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy","volume":"92","author":"Rosenthal","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0945","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2163784","article-title":"Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease","volume":"12","author":"Shrestha","year":"2023","journal-title":"OncoImmunology"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103279","article-title":"Addition of plerixafor for mobilization of stem cells with bortezomib is feasible in dialysis-dependent multiple myeloma","volume":"60","author":"Taenaka","year":"2021","journal-title":"Transfus. Apher. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0955","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1158\/1078-0432.CCR-11-1407","article-title":"Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma","volume":"18","author":"Petrich","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb0960","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjh.14232","article-title":"A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma","volume":"175","author":"Park","year":"2016","journal-title":"Brit. J. Haematol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb0965","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.2009.24.1570","article-title":"Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative Disorders","volume":"28","author":"Lin","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb0970","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-198512000-00022","article-title":"Splenic injury sustained from blunt abdominal trauma","volume":"202","author":"Cooper","year":"1985","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb0975","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1055\/s-0042-116817","article-title":"Extraluminal migration of an esophageal metal stent causing splenic injury","volume":"48","author":"Khan","year":"2016","journal-title":"Endoscopy"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0980","doi-asserted-by":"crossref","first-page":"635","DOI":"10.51821\/85.3.11004","article-title":"Splenic injury during colonoscopy: modern treatment approach and splenic salvage","volume":"85","author":"Lukies","year":"2022","journal-title":"Acta Gastro-Enterol. Belg."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb0985","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/diagnostics9040152","article-title":"Spontaneous Splenic Rupture as a Rare Initial Presentation in an Acute Lymphoblastic Leukemia Patient","volume":"9","author":"Wu","year":"2019","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb0990","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231196818","article-title":"Spontaneous rupture of the spleen at full term during pregnancy: a case report","volume":"51","author":"Xu","year":"2023","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb0995","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13017-021-00353-4","article-title":"The management and outcome of paediatric splenic injuries in the Netherlands","volume":"16","author":"Grootenhaar","year":"2021","journal-title":"World J. Emergen. Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1000","series-title":"Update on Nonoperative Management of the Injured Spleen","author":"Harfouche","year":"2022"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1005","series-title":"Splenic trauma in children, Surgery, gynecology & obstetrics","author":"Upadhyaya","year":"1968"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb1010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/bjs.7203","article-title":"Management of blunt injuries to the spleen","volume":"97","author":"Renzulli","year":"2010","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb1015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1445-2197.2010.05591.x","article-title":"Factors predicting the need for splenectomy in children with blunt splenic trauma","volume":"81","author":"Fick","year":"2012","journal-title":"ANZ J. Surg."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/TA.0000000000003833","article-title":"Recent trends in the management of isolated high-grade splenic injuries: A nationwide analysis","volume":"94","author":"Aoki","year":"2022","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijid.2020.07.013","article-title":"Risk of invasive pneumococcal disease in patients with asplenia\/hyposplenism: A nationwide population-based study in Korea, 2009\u20132018","volume":"98","author":"Kang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0950268816002405","article-title":"Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study","volume":"145","author":"Chong","year":"2016","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13054-020-2769-y","article-title":"n. null, Pneumococcal purpura fulminans in asplenic or hyposplenic patients: a French multicenter exposed-unexposed retrospective cohort study","volume":"24","author":"Contou","year":"2020","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jvs.2012.02.027","article-title":"Associated injuries, management, and outcomes of blunt abdominal aortic injury","volume":"56","author":"de Mestral","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1045","article-title":"Feasibility of non-operative management for patients sustained blunt splenic traumas with concomitant aortic injuries","author":"Jen-Fu","year":"2023","journal-title":"Eur. J. Trauma Emerg. Surg."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/TA.0000000000001557","article-title":"The spleen not taken: Differences in management and outcomes of blunt splenic injuries in teenagers cared for by adult and pediatric trauma teams in a single institution","volume":"83","author":"O\u02bcConnor","year":"2017","journal-title":"J. Trauma Acute Care Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1055","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jvir.2013.01.326","article-title":"Distal embolization for blunt traumatic splenic injuries: efficacy and complications","volume":"24","author":"Shah","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1060","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003755","article-title":"The Long-term Risk of Venous Thromboembolism After Blunt Splenic Injury Managed by Embolization","volume":"271","author":"Mulder","year":"2020","journal-title":"Ann. Surg."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb1065","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00383-020-04750-9","article-title":"Risk factors associated with splenectomy following a blunt splenic injury in pediatric patients","volume":"36","author":"Knight","year":"2020","journal-title":"Pediatr. Surg. Int."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/aogs.14286","article-title":"Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study","volume":"101","author":"Said","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1075","doi-asserted-by":"crossref","first-page":"106420","DOI":"10.1016\/j.intimp.2020.106420","article-title":"Spleen contributes to restraint stress induced hepatocellular carcinoma progression","volume":"83","author":"Jiang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1080","article-title":"The impact of splenectomy on human lipid metabolism, Ups","volume":"127","author":"Gunes","year":"2022","journal-title":"J. Med. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1085","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00268-017-4336-5","article-title":"Long-Term Follow-Up After Non-operative Management of Blunt Splenic and Liver Injuries: A Questionnaire-Based Survey","volume":"42","author":"Moreno","year":"2017","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bjs.1800780904","article-title":"Postsplenectomy sepsis and its mortality rate: actual versus perceived risks","volume":"78","author":"Holdsworth","year":"1991","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb1095","article-title":"A single-center prospective cohort study on post-splenectomy sepsis and its prevention","volume":"11","author":"Rieg","year":"2020","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jpedsurg.2018.06.024","article-title":"Incidence and risk factors for sepsis after childhood splenectomy","volume":"54","author":"Madenci","year":"2018","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1105","article-title":"Spleen-Preserving Surgery in Splenic Artery Aneurysm, Case Report","volume":"2017","author":"Aday","year":"2017","journal-title":"Surger"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1110","first-page":"678","article-title":"Is spleen-preserving surgery safe for abdominal trauma?","volume":"91","author":"G\u00f3mez-S\u00e1nchez","year":"2023","journal-title":"Cirugia y cirujanos"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1115","article-title":"Progress of polysaccharide-based tissue adhesives","volume":"327","author":"Gi-Yeon","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1120","article-title":"Oxidized cellulose-based hemostatic materials","volume":"230","author":"Zhang","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ASW.0000000000000036","article-title":"Closure of Long Surgical Incisions with Hemostatic Tissue Adhesive in a Porcine Skin Model","volume":"36","author":"Neiman","year":"2023","journal-title":"Adv. Skin Wound Care"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2147\/OTT.S151219","article-title":"Fast hemostasis: a win-win strategy for ultrasound and microwave ablation","volume":"11","author":"Guo","year":"2018","journal-title":"Onco. Targets Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb1135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.1976.03270130045028","article-title":"Gastric Hemostasis by Laser Phototherapy in Man","volume":"236","author":"Dwyer","year":"1976","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.gassur.2005.01.216","article-title":"Spleen preservation surgery with radiofrequency ablation","volume":"9","author":"Jiao","year":"2005","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1145","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1016\/j.hpb.2016.03.437","article-title":"A prospective cohort study of radiofrequency-assisted splenic preservation and conventional treatment of blunt splenic injury","volume":"18","author":"Ma","year":"2016","journal-title":"HPB"},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.007_bb1150","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s002689900169","article-title":"Hemostatic methods for the management of spleen and liver injuries","volume":"20","author":"Uran\u00fcs","year":"1996","journal-title":"World J. Surg."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1155","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00595-020-02177-2","article-title":"Laparoscopic surgery for splenic injuries in the era of non-operative management: current status and future perspectives","volume":"51","author":"Romeo","year":"2020","journal-title":"Surg. Today"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM194605092341902","article-title":"Multiple peritoneal autotransplantation of splenic tissue following traumatic rupture of the spleen","volume":"234","author":"Waugh","year":"1946","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1165","doi-asserted-by":"crossref","unstructured":"S.T.F. Grunewald, A.B. Rezende, B.B.M. Figueiredo, A.C.D.P. Mendon\u00e7a, C.D.S. Almeida, E.E. de Oliveira, F. de Paoli, H.C. Teixeira. (2016). Autotransplantation of Spleen Mitigates Drug-Induced Liver Damage in Splenectomized Mice, J. Investig. Surg. 30(6), 368\u2013375.","DOI":"10.1080\/08941939.2016.1255806"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bjs.1800790140","article-title":"Regeneration of the spleen and splenic autotransplantation","volume":"79","author":"Pabst","year":"1992","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13017-020-00299-z","article-title":"Single segment of spleen autotransplantation, after splenectomy for trauma, can restore splenic functions","volume":"15","author":"Toro","year":"2020","journal-title":"World J. Emergen. Surg."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1553350611419867","article-title":"A new technique for spleen autotransplantation","volume":"19","author":"Di Carlo","year":"2011","journal-title":"Surg. Innov."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2017.11.011","article-title":"Splenomegaly: Pathophysiological bases and therapeutic options","volume":"94","author":"McKenzie","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/ceji.2017.72825","article-title":"Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency","volume":"42","author":"Bazregari","year":"2017","journal-title":"Centr. European J. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1195","series-title":"The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies, Endocrine, Metabolic & Immune Disorders - Drug Targets","author":"Azizi","year":"2018"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb1200","first-page":"23","article-title":"Piecing together the subtle clues of common variable immunodeficiency","volume":"36","author":"Kochanoff","year":"2023","journal-title":"J. American Acad. Phys. Assist."},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.007_bb1205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","article-title":"Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice","volume":"3","author":"Garchow","year":"2011","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13223-023-00840-0","article-title":"Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase \u03b4 syndrome 1","volume":"19","author":"Jiang","year":"2023","journal-title":"Allergy, Asthma & Clin. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1215","article-title":"Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling","volume":"9","author":"Amani","year":"2019","journal-title":"Sci. Rep-Uk"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb1220","doi-asserted-by":"crossref","first-page":"103442","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb1225","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2169\/internalmedicine.6694-20","article-title":"Progressive Massive Splenomegaly in an Adult Patient with Kabuki Syndrome Complicated with Immune Thrombocytopenic Purpura","volume":"60","author":"Mushino","year":"2021","journal-title":"Intern. Med."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1230","series-title":"Clue to the cause of portal hypertension: Look at the raindrops","author":"Mishra","year":"2019"},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1235","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/1535370217693113","article-title":"Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly","volume":"242","author":"Lv","year":"2017","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14728214.2016.1184647","article-title":"Emerging therapies for portal hypertension in cirrhosis","volume":"21","author":"Nair","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.007_bb1245","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171015","article-title":"The beneficial effects of curcumin in cirrhotic rats with portal hypertension","volume":"37","author":"Hsu","year":"2017","journal-title":"Biosci. Rep."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1250","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1097\/MS9.0000000000001122","article-title":"Esophageal variceal bleeding: portal hypertension and portal vein thrombosis secondary to protein S deficiency - a case report","volume":"85","author":"Sapkota","year":"2023","journal-title":"Ann. Med. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1255","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13256-016-1059-4","article-title":"Coexisting giant splenic artery and portal vein aneurysms leading to non-cirrhotic portal hypertension: a case report","volume":"10","author":"Khan","year":"2016","journal-title":"J. Med. Case Rep."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1260","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1177\/0300060518767550","article-title":"Distribution characteristics of cells in splenomegaly due to hepatitis B-related cirrhotic portal hypertension and their clinical importance","volume":"46","author":"Han","year":"2018","journal-title":"J. Int. Med. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1265","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.10.035","article-title":"Surgical management of portal hypertension in Felty\u2019s syndrome: A case report and literature review","volume":"50","author":"Stock","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/CEG.S188200","article-title":"Combination of modified Sugiura technique and proximal splenorenal shunt for the management of portal vein thrombosis in noncirrhotic portal hypertension","volume":"12","author":"Irawan","year":"2019","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.1985.34.119","article-title":"Regression of splenomegaly and hepatomegaly in children treated for Schistosoma haematobium infection","volume":"34","author":"Stephenson","year":"1985","journal-title":"Am. J. Trop. Med. Hygien."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1280","doi-asserted-by":"crossref","first-page":"242","DOI":"10.14309\/ajg.0000000000002549","article-title":"Disseminated Melioidosis Infection Involving Hepatosplenomegaly and Massive Extramedullary Hematopoiesis","volume":"119","author":"Prasoppokakorn","year":"2023","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb1285","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMicm1905550","article-title":"Massive Splenomegaly from Disseminated Mycobacterium avium\u2013intracellulare Infection","volume":"382","author":"Massoth","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1290","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2017.06.005","article-title":"B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection","volume":"489","author":"Omachi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb1295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010962","article-title":"Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse","volume":"16","author":"Paterson","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1300","first-page":"002477","article-title":"Coombs-Negative Haemolytic Anaemia, Direct Hyperbilirubinaemia and Splenomegaly: A Rare Amalgam","volume":"8","author":"Kulkarni","year":"2021","journal-title":"European J. Case Report. Internal Med."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/hiv.13390","article-title":"Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection","volume":"24","author":"Kablawi","year":"2022","journal-title":"HIV Med"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1310","doi-asserted-by":"crossref","first-page":"704635","DOI":"10.3389\/fped.2021.704635","article-title":"Splenomegaly in children and adolescents","volume":"9","author":"Suttorp","year":"2021","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1023\/A:1005446418589","article-title":"Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen","volume":"45","author":"Tsushima","year":"2000","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1320","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/children10050869","article-title":"Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma","volume":"10","author":"Boss\u00f9","year":"2023","journal-title":"Children"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.007_bb1325","first-page":"003705","article-title":"One of the Few Causes of Massive Splenomegaly","volume":"9","author":"Gar\u00e7a","year":"2022","journal-title":"European J. Case Report. Internal Med."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1330","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00431-012-1771-z","article-title":"Revised recommendations for the management of Gaucher disease in children","volume":"172","author":"Kaplan","year":"2012","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1335","first-page":"691","article-title":"Splenomegaly (SPML) in Polycythemia Vera (PV): Its Clinical Significance and Relation to Myelofibrosis and Survival","volume":"37","author":"Silver","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1340","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41375-018-0214-x","article-title":"Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions","volume":"32","author":"Heidel","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41375-018-0304-9","article-title":"Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?","volume":"33","author":"Teofili","year":"2018","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1350","first-page":"1591","article-title":"Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study","volume":"97","author":"Passamonti","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.007_bb1355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1470-2045(16)30558-7","article-title":"Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study","volume":"18","author":"Passamonti","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1360","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.4081\/hr.2019.8281","article-title":"Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study","volume":"11","author":"Accurso","year":"2019","journal-title":"Hematol. Rep."},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb1365","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e87","article-title":"Volumetric Splenomegaly in Patients With Polycythemia Vera","volume":"37","author":"Lee","year":"2022","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1370","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/ijms19030898","article-title":"Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis","volume":"19","author":"Song","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1375","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1111\/jcmm.13710","article-title":"Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis","volume":"22","author":"Corey","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1380","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-020-04069-4","article-title":"Modern management of splenomegaly in patients with myelofibrosis","volume":"99","author":"Tremblay","year":"2020","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1385","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.jvir.2019.12.457","article-title":"Abstract No, 396 Partial splenic artery embolization: a nonsurgical approach to hypersplenism","volume":"31","author":"Moideen","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.007_bb1390","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/000313481708300323","article-title":"Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis: A Meta-Analysis","volume":"83","author":"Wang","year":"2017","journal-title":"Am. Surg."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.007_bb1395","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1400","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ajh.21799","article-title":"Effective management of accelerated phase myelofibrosis with low-dose splenic radiotherapy","volume":"85","author":"Pardanani","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"21","key":"10.1016\/j.jconrel.2024.05.007_bb1405","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/smll.201203106","article-title":"Graphene nanomesh promises extremely efficient in vivo photothermal therapy","volume":"9","author":"Akhavan","year":"2013","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1410","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.biomaterials.2011.11.064","article-title":"The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power","volume":"33","author":"Yang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1415","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.msec.2014.09.019","article-title":"In vivo SPECT imaging of tumors by 198,199Au-labeled graphene oxide nanostructures","volume":"45","author":"Fazaeli","year":"2014","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.007_bb1420","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/17435390.2020.1778809","article-title":"Possible effects of titanium dioxide particles on human liver, intestinal tissue, spleen and kidney after oral exposure","volume":"14","author":"Brand","year":"2020","journal-title":"Nanotoxicology"},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1425","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.201800540","article-title":"Simultaneous Quantification and Visualization of Titanium Dioxide Nanomaterial Uptake at the Single Cell Level in an In Vitro Model of the Human Small Intestine","volume":"3","author":"Meyer","year":"2019","journal-title":"Small Meth."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.007_bb1430","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17435390.2017.1306893","article-title":"Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2","volume":"11","author":"Kreyling","year":"2017","journal-title":"Nanotoxicology"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.007_bb1435","doi-asserted-by":"crossref","first-page":"11386","DOI":"10.1021\/acsanm.1c01907","article-title":"Review of Oxygenation with Nanobubbles: Possible Treatment for Hypoxic COVID-19 Patients","volume":"4","author":"Afshari","year":"2021","journal-title":"Acs. Appl. Nano Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2024.05.007_bb1440","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.7150\/thno.41850","article-title":"Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression","volume":"10","author":"Khan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1445","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.actbio.2020.03.034","article-title":"Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer","volume":"108","author":"Song","year":"2020","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1450","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine-Uk"},{"key":"10.1016\/j.jconrel.2024.05.007_bb1455","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-018-0256-8","article-title":"Hesperidin alleviates zinc oxide nanoparticle induced hepatotoxicity and oxidative stress","volume":"19","author":"Ansar","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2024.05.007_bb1460","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biopha.2017.03.089","article-title":"Toxicity of titanium dioxide nanoparticles: Effect of dose and time on biochemical disturbance, oxidative stress and genotoxicity in mice","volume":"90","author":"Rizk","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.007_bb1465","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1166\/jbn.2020.2921","article-title":"Liver Inflammation and Fibrosis Induced by Long-Term Exposure to Nano Titanium Dioxide (TiO) Nanoparticles in Mice and Its Molecular Mechanism","volume":"16","author":"Hong","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"issue":"46","key":"10.1016\/j.jconrel.2024.05.007_bb1470","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303614","article-title":"Esterase-Labile Quaternium Lipidoid Enabling Improved mRNA-LNP Stability and Spleen-Selective mRNA Transfection","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924002918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:11:22Z","timestamp":1740211882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924002918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":294,"alternative-id":["S0168365924002918"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spleen-targeted delivery systems and strategies for spleen-related diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}